Influence of COVID-19 pandemic on the decision making of patients in undergoing gamma knife radiosurgeryArticle Published on 2022-10-292022-11-16 Journal: European Journal of Medical Research [Category] 변종, [키워드] affected age analyses analyzed approach approval attenuate characteristic co-morbidity collected Comorbidity control group COVID-19 COVID-19 pandemic COVID-19 vaccination database decision Decision making Diagnosis Follow-up Frequency Gamma Gamma knife influence lesion lesions less MRI neurological Neurological deficit pandemic parameter Patient patients treated performance proportion Radiation Radiation dose Radiosurgery Sex status time interval treated Treatment vaccination vaccination. variant Volume [DOI] 10.1186/s40001-022-00859-w PMC 바로가기
Serum Proteome Signatures of Anti-SARS-CoV-2 Vaccinated Healthcare Workers in Greece Associated with Their Prior Infection StatusArticle Published on 2022-09-052022-11-15 Journal: International Journal of Molecular Sciences [Category] SARS, 유전자 메커니즘, 진단, [키워드] affected All participant analyzed anti-SARS-CoV-2 anti-SARS-CoV-2 vaccination approach bioinformatics blood sample BNT162b2 mRNA Characteristics collected contribute contributed controls Course COVID-19 COVID-19 vaccination COVID-19 vaccine database differentially expressed down-regulated Gene ontology Greece humoral immune response identify IgG immune response Immune status individuals infected patient KEGG knowledge Kyoto LC-MS/MS majority mechanism molecular over pandemic pathogenic pathway Pfizer/BioNTech processed profiling analysis Protein proteome proteomics provided Quantitative RBD-specific IgG recipients Research SARS-CoV-2 SARS-COV-2 infection sera serum signature significantly status the SARS-CoV-2 Thessaloniki titer vaccinated individual vaccination vaccination. Vaccine virus worker [DOI] 10.3390/ijms231710153 PMC 바로가기
Association between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational StudiesArticle Published on 2022-09-012022-11-15 Journal: Journal of the American Nutrition Association [Category] 바이오마커, [키워드] 25-hydroxyvitamin D3 95% CI age analyzed association Biomarkers C-reactive protein cardiovascular diseases Concentration conducted Controlled trial COVID-19 COVID-19 infection COVID-19 patient COVID-19 severity death deaths defined Developing Effect elevated eligibility Evidence examined greater higher risk Hospital stay hypertension IMPROVE increased risk independent Inflammatory interleukin-6 Invasive mechanical ventilation investigator male marker mechanism Meta-analysis observational study outcome outcomes participant pathway Patient peak D-dimer Prevalence Research risk serum serum troponin severe COVID-19 Severe COVID-19 Infection Severe COVID-19 pneumonia severity statistically status the patient Vitamin D vitamin D insufficiency vitamin D level vitamin D levels Vitamin D status [DOI] 10.1080/07315724.2021.1951891 PMC 바로가기
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies혈액암이 있는 성인 환자의 SARS-CoV-2 백신 1차 및 2차 접종에 대한 면역 반응의 체계적인 검토 및 메타 분석Review Published on 2022-09-012022-09-11 Journal: International immunopharmacology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] 95% confidence interval 95%CI affected affecting anti-CD20 therapy antibody Antibody detection Antibody Response article booster dose booster doses calculated Cancer patients chronic lymphocytic leukemia CLL Complete conducted coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines develop Diagnosis disease doses evaluate first dose Google Google Scholar healthy subject healthy subjects Hematological malignancies Hematological malignancy higher risk highlight highlighting immune response Immunity immunization Immunocompromised immunogenicity immunosuppressive IMPROVE kinase inhibitors less leukemia lowest Lymphocytic leukemia lymphoma malignancy measure Meta-analysis mRNA mRNA-1273 Myeloma Patient Primary outcome response rate SARS-CoV-2 SARS-CoV-2 vaccine second dose secondary outcome Secondary outcomes seropositive Seropositivity severe coronavirus disease solid tumor solid tumors status subgroup subtype systematic review systematic review. the disease the vaccine tumors tyrosine tyrosine kinase inhibitor tyrosine kinase inhibitors Vaccine vaccine dose vaccine's immunogenicity Web of Science [DOI] 10.1016/j.intimp.2022.109046 PMC 바로가기 [Article Type] Review
COVID-19 Antibody Status and Its Impact on the Severity of Dengue Fever among Children: An Observational StudyCOVID-19 항체 상태 및 아동의 뎅기열 중증도에 미치는 영향: 관찰 연구Observational Study Published on 2022-09-012022-09-12 Journal: Indian journal of pediatrics [Category] MERS, 임상, 진단, [키워드] COVID-19 Dengue Impact status [DOI] 10.1007/s12098-022-04266-1 PMC 바로가기 [Article Type] Observational Study
Serologic Status and SARS-CoV-2 Infection over 6 Months of Follow Up in Healthcare Workers in Chicago: A Cohort StudyArticle Published on 2022-09-012022-11-15 Journal: Infection Control and Hospital Epidemiology [Category] SARS, 진단, [키워드] 95% confidence interval Abbott adjusted analyzed anti-Nucleocapsid IgG antibody status baseline Baseline serology baseline serostatus changes in checked Chicago cohort study coronavirus disease COVID-19 criteria demographics determine Follow-up HCW HCWs healthcare worker identify Infection median moderate Month participant PCR PCR positive polymerase chain positive positive PCR Prospective recruited Reinfection Respiratory Coronavirus risk SARS-CoV-2 SARS-COV-2 infection seroconverted serologic serology serology testing seronegative seronegative participant seropositive Seropositivity setting status virus was used were assessed worker [DOI] 10.1017/ice.2021.367 PMC 바로가기
Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational StudyPost-mRNA 예방접종 후 중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2) 면역글로불린 G(IgG) 농도 및 HIV(인간면역결핍바이러스)에 의한 대리바이러스 중화시험 반응의 차이 백신의 상태 및 유형: 일치된 사례-대조군 관찰 공부하다Observational Study Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 임상, 진단, [키워드] acute respiratory syndrome BNT162b2 vaccine CD4+ T-cell coronavirus coronavirus 2 COVID-19 difference HIV Human Human immunodeficiency virus IgG immune immune response Immunoglobulin Immunoglobulin G Matched mRNA vaccination PLWH respiratory response SARS-CoV-2 status surrogate Test Type vaccination vaccination. vaccine dose virus neutralization test [DOI] 10.1093/cid/ciab1009 PMC 바로가기 [Article Type] Observational Study
Ad-hoc preoperative management and respiratory events in pediatric anesthesia during the first COVID-19 lockdown-an observational cohort studyObservational Study Published on 2022-08-182022-10-05 Journal: PLoS ONE [Category] 임상, [키워드] ad-hoc airway airway manipulation Analysis Anesthesiology children clinical contribute COVID-19 Elective surgery Endotracheal intubation event events general anesthesia intraoperative lockdown management National no significant difference Observational cohort study parameter Patient pediatric peripheral oxygen saturation Primary outcome Registered Regression Risk factors significant difference Society SpO2 status unique younger patient [DOI] 10.1371/journal.pone.0273353 PMC 바로가기 [Article Type] Observational Study
AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trialClinical Trial Published on 2022-08-162022-10-04 Journal: Frontiers in Public Health [Category] SARS, 임상, 진단, [키워드] Analysis Anu AYURAKSHA kit Ayurveda Blood blood sugar C-reactive protein CD3 CD4 CD8 clinical control group controls COVID-19 COVID-19 crisis COVID-19 infection COVID-19 pandemic determine distribution dysregulated effective Efficacy effort erythrocyte sedimentation rate evaluated hematological hematological parameter hematological parameters IgG IgG positivity IL-6 IL-6 level Immunity incidence India Infection inflammation marker Intervention life lower risk Lymphocyte subset management Medicine Mortality no increase non-randomized pandemic participant Participants post-intervention Primary outcome Prophylactic Quality Quality of life quality of life (QOL). random reduced reducing Research secondary outcome severity of COVID-19 significantly significantly lower status the WHO Trial Version [DOI] 10.3389/fpubh.2022.920126 PMC 바로가기 [Article Type] Clinical Trial
Breakthrough COVID-19 Infection During the Delta Variant Dominant Period: Individualized Care Based on Vaccination Status Is NeededArticle Published on 2022-08-152022-11-16 Journal: Journal of Korean medical science [Category] SARS, 변종, [키워드] abnormality age analyzed Breakthrough infection chest X-ray Clinical characteristics clinical feature Comorbidity coronavirus disease COVID-19 COVID-19 patient COVID-19 vaccination Delta Diabetes Mellitus elevated group Hospitalized hospitalized COVID-19 patient initial lactate dehydrogenase less National numbers of patient Older oxygen Oxygen therapy Patient patients progression proportion protective factor risk risk factor SARS-CoV-2 Severe Progression. solid cancer status symptomatic two groups vaccination were assessed X-ray [DOI] 10.3346/jkms.2022.37.e252 PMC 바로가기